Cannabis-based drug under development for Tourette
Therapix Biosciences’ first-in-class, proprietary investigational drug candidate is to be developed into a softgel product in the US.
Therapix Biosciences’ first-in-class, proprietary investigational drug candidate is to be developed into a softgel product in the US.